이상반응 보고
VAERS ID | 2178838 |
---|---|
성별 | 남성 |
나이 | 54세 |
주 코드 | FR |
제약회사 | JANSSEN |
로트 번호 | ACB7542 |
예방접종 횟수 | 1 |
접종일 | |
발병일 | 2022-03-02 |
상태 | 사망 |
증상
- 호흡곤란(Dyspnoea)
이환 중 질병
지병
기타 의료
이전 예방접종
알레르기
임상 검사
증상 상세
DIFFICULTY BREATHING; This spontaneous report received from a health care professional by a Regulatory Authority on 10-MAR-2022, concerned a 54 year old male of unspecified race and ethnicity.
The patient's height, and weight were not reported.
No past medical history or concurrent conditions were reported.
The patient received covid-19 vaccine ad26.
cov2.
s (suspension for injection, intramuscular, batch number: ACB7542 and expiry: UNKNOWN) dose was not reported, 1 total administered on 04-FEB-2022 for an unspecified indication.
No concomitant medications were reported.
On 02-MAR-2022; at 02:00, the patient experienced difficulty breathing.
On 03-MAR-2022; at 04:40, the patient died from difficulty breathing.
It was unknown if an autopsy performed.
The action taken with covid-19 vaccine ad26.
cov2.
s was not applicable.
This report was serious (Death).
; Sender's Comments: V0- 20220325788 -Covid-19 vaccine ad26.
CoV-2.
s-Difficulty breathing .
The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility.
There is no information on any other factors potentially associated with the event(s).
Therefore, this event(s) is considered unassessable.
; Reported Cause(s) of Death: DIFFICULTY BREATHING